维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Allmer C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，66：	1
2	Phase Ⅱ study oferlotinib in patients with advanced biliary cancer显示文摘	Philip PA Mahoney MR Allmer C		0，，19：	1
3	Phase Ⅱ study of erlotinib (OSI-774) in patients with advanced hepatocelluar显示文摘	Philip AP Mahoney MR Allmer C	2005	Cancer J Clin Oncol2005，23，：	1
4	Phase Ⅱ study of erlotinib (OSI-774) in patients with advanced biliary cancer显示文摘	Philip AP Mahoney MR Allmer C	2006	J Clin Oncol2006，24，：	1
5	Phase Ⅱ study of erlotinib in patients with advanced biliary cancer 显示文摘	Philip P A Mahoney M R Allmer C	2006	J Clin Oncol2006，24，19：	1
6	Phase Ⅱ study of erlo- finib in patients with advanced biliary cancer显示文摘	Philip PA Mahoney MR Allmer C	2006	J Grin Oncol2006，24，19：	1
7	Lymph node dissec-tion at the time of radical nephrectomy for high - risk clear cell renal cell carcinoma: indications and recommendations for surgical templates 显示文摘	Crispen PL Breau RH Allmer C	2011	Eur Urol2011，59，1：	1
8	Phase Ⅱstudy of erlotinib (OSI-774)in patients with advanced hepatocellular cancer显示文摘	PHILIP PA MAHONEY MR ALLMER C	2005	J Clin Oncol2005，23，27：	1
9	Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma:indications and recommendations for surgical templates显示文摘	Crispen PL Breau RH Allmer C	2011	European Urology2011，59，1：	1
10	Phase II study of erlotinib in patients with advanced biliary cancer显示文摘	PHILIP PA MAHONEY MR ALLMER C	2006	J Clin Oncol2006，24，19：	1
11	Phase II study of Erlotinib(OSI-774) in patients with advanced hepatocellular cancer 显示文摘	Philip PA Mahoney MR Allmer C	2005	Journalof Clinical Oncology2005，23，：	1
12	Phase II study of Erlotinib (OSI -774) in patients with advanced hepatocellular cancer 显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，27：	1
13	Phase 11 study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，27：	1
14	Phase II study of erlotinib (0SI-774) in patients with advanced hepatocellular cancer显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，：	1
15	Phase It study of erlotinib in patients with advanced biliary cancer显示文摘	Philip PA Mahoney MR Allmer C	2006	J Clin Oncol2006，24，19：	1
16	Phase Ⅱ study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin 0ncol2005，23，27：	1
17	Phase Ⅱ study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，27：	1
18	Phase Ⅱ study of Erlo- tinib (0SI-774) in patients with advanced hepatocellular cancer 显示文摘	Philip PA Mahoney MR Allmer C	2005	J Clin Oncol2005，23，27：	1
19	Phase II study of Erlotinib (OSl -774) in patients with advanced hepatocellular cancer显示文摘	PHILIP PA MAHQNEY MR ALLMER C	2005	J Clin Oncol2005，2327，：	1
20	Unclassified renal cell carcinoma:Impact on survival following neuphrectomy显示文摘	Crispen PL Tabidain MR Allmer C	2010	Urology2010，76，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示